Overview and critical revision of clinical assessment tools in chemotherapy‐induced peripheral neurotoxicity
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overview and critical revision of clinical assessment tools in chemotherapy‐induced peripheral neurotoxicity
Authors
Keywords
-
Journal
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
Volume 24, Issue S2, Pages -
Publisher
Wiley
Online
2019-10-25
DOI
10.1111/jns.12333
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patients' and physicians' interpretation of chemotherapy‐induced peripheral neurotoxicity
- (2019) Guido Cavaletti et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- The National Cancer Institute Clinical Trials Planning Meeting for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
- (2019) Susan G Dorsey et al. JNCI-Journal of the National Cancer Institute
- Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy
- (2019) Alex Molassiotis et al. BMC CANCER
- Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings
- (2019) Andreas A Argyriou et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Ca
- (2018) Hui Lin Cheng et al. Asia-Pacific Journal of Clinical Oncology
- Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data
- (2018) Ellen M. Lavoie Smith et al. CANCER NURSING
- Reliability and validity of the Chinese version neuropathic pain symptom inventory in patients with colorectal cancer
- (2018) Ling-Chun Lu et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials
- (2018) Ellen M. Lavoie Smith et al. Cancer Control
- Trial designs for chemotherapy-induced peripheral neuropathy prevention
- (2018) Jennifer S. Gewandter et al. NEUROLOGY
- Concept domain validation and item generation for the Treatment-Induced Neuropathy Assessment Scale (TNAS)
- (2018) Loretta A. Williams et al. SUPPORTIVE CARE IN CANCER
- Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data
- (2018) Ellen M. Lavoie Smith et al. SUPPORTIVE CARE IN CANCER
- The psychometric properties of the Turkish version of the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool (CIPNAT)
- (2017) Sevinç Kutlutürkan et al. European Journal of Oncology Nursing
- Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)
- (2017) Jacobien M. Kieffer et al. QUALITY OF LIFE RESEARCH
- Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy
- (2017) Robert Knoerl et al. SUPPORTIVE CARE IN CANCER
- Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey
- (2017) J . Matt McCrary et al. SUPPORTIVE CARE IN CANCER
- Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials
- (2017) Jennifer Le-Rademacher et al. SUPPORTIVE CARE IN CANCER
- Content validity of symptom-based measures for diabetic, chemotherapy, and HIV peripheral neuropathy
- (2016) Jennifer S. Gewandter et al. MUSCLE & NERVE
- A PROMIS Measure of Neuropathic Pain Quality
- (2016) Robert L. Askew et al. VALUE IN HEALTH
- Validity of the Chemotherapy-induced Peripheral Neuropathy Self-Check Sheet
- (2015) Yumiko Miyoshi et al. INTERNAL MEDICINE
- Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale
- (2015) Tito R. Mendoza et al. JOURNAL OF PAIN
- Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc©) in patients with chemotherapy-induced peripheral neuropathy
- (2015) Davide Binda et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Reliability testing of oxaliplatin-associated neurotoxicity questionnaire (OANQ), a pilot study
- (2015) E. Gustafsson et al. SUPPORTIVE CARE IN CANCER
- Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice
- (2015) A. J. M. Beijers et al. SUPPORTIVE CARE IN CANCER
- Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
- (2015) Amylou C. Dueck et al. JAMA Oncology
- Prevalence of pain and relative diagnostic performance of screening tools for neuropathic pain in cancer patients: A cross-sectional study
- (2014) C. Pérez et al. EUROPEAN JOURNAL OF PAIN
- Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin
- (2013) P. Alberti et al. ANNALS OF ONCOLOGY
- Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)
- (2013) D. Binda et al. EUROPEAN JOURNAL OF CANCER
- Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire
- (2013) Ellen M. Lavoie Smith et al. QUALITY OF LIFE RESEARCH
- The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
- (2012) G. Cavaletti et al. ANNALS OF ONCOLOGY
- Development and Psychometric Evaluation of the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool
- (2011) Cindy S. Tofthagen et al. CANCER NURSING
- Discrepancy between the NCI-CTCAE and DEB-NTC scales in the evaluation of oxaliplatin-related neurotoxicity in patients with metastatic colorectal cancer
- (2011) Naohiko Inoue et al. International Journal of Clinical Oncology
- Precise evaluation of chemotherapy-induced peripheral neuropathy using the visual analogue scale: a quantitative and comparative analysis of neuropathy occurring with paclitaxel–carboplatin and docetaxel–carboplatin therapy
- (2011) Shuji Takemoto et al. International Journal of Clinical Oncology
- Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale
- (2011) Barbara Frigeni et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Assessing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients
- (2011) C. M. L. Driessen et al. SUPPORTIVE CARE IN CANCER
- The Reliability and Validity of a Modified Total Neuropathy Score-Reduced and Neuropathic Pain Severity Items When Used to Measure Chemotherapy-Induced Peripheral Neuropathy in Patients Receiving Taxanes and Platinums
- (2010) Ellen M. Lavoie Smith et al. CANCER NURSING
- Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools
- (2010) Guido Cavaletti et al. EUROPEAN JOURNAL OF CANCER
- Neuropathic Pain in Breast Cancer Survivors: Using the ID Pain as a Screening Tool
- (2010) Cielito Reyes-Gibby et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties
- (2010) Kathleen A. Griffith et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Exercise and cancer rehabilitation: A systematic review
- (2009) Rosalind R. Spence et al. CANCER TREATMENT REVIEWS
- Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02
- (2009) Kojiro Shimozuma et al. SUPPORTIVE CARE IN CANCER
- A Questionnaire Survey of Physicians' Perspectives Regarding the Assessment of Chemotherapy-induced Peripheral Neuropathy in Patients with Breast Cancer
- (2008) K. Kuroi et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Development of a Novel Location-Based Assessment of Sensory Symptoms in Cancer Patients: Preliminary Reliability and Validity Assessment
- (2008) Adam R. Burkey et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More